<DOC>
	<DOCNO>NCT02918474</DOCNO>
	<brief_summary>An online decision support tool field test provide patient face decision contralateral prophylactic breast cancer ( CPM ) evidence-based information expect incidence contralateral breast cancer life expectancy benefit CPM . The tool design use clinical setting view jointly patient physician part share decision make process around CPM .</brief_summary>
	<brief_title>Decision Making Tool Contralateral Prophylactic Mastectomy</brief_title>
	<detailed_description>Potential participant recruit initial surgeon 's appointment MD Anderson Cancer Center ( MDACC ) . For K-S site , potential participant recruit initial surgeon 's visit patient come know breast cancer diagnosis . Eligible participant ' surgical treatment preference assess prior meeting surgeon include level interest CPM ( i.e. , interest CPM definitely interested CPM ) . If participant selects 3 high interest CPM ( 1 indicate interest CPM 5 indicate definite interest CPM ) , patient invite participate study . Five breast cancer surgeon invite participate study ask field test decision tool 5 eligible patient consider CPM . The patient ' acceptability effectiveness decision support tool assess use questionnaire patient participates consultation breast cancer surgeon . Patients ' rating acceptability decision support tool assess use question Ottawa Acceptability Measures , include clarity , amount , balance information provide tool ( 2 ) . The effectiveness decision support tool assess follow measure administer consultation : 1 ) change patient 's knowledge CPM 2 ) reduction decisional conflict CPM use Decisional Conflict Scale ( 3 ) Patients also ask preference CPM consultation .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Newly diagnose ductal carcinoma situ ( DCIS ) stage IIII sporadic unilateral invasive breast cancer 2 . Age 18 old 2 ) Able speak read write English 1 . Patients previous breast cancer 2 . Prior history bilateral prophylactic mastectomy 3 . Known germline mutation predisposes increase risk breast cancer ( e.g . BRCA1/2 ) and/or consider high risk contralateral breast cancer basis strong family history cancer .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Contralateral prophylactic breast cancer</keyword>
	<keyword>CPM</keyword>
	<keyword>Breast cancer surgery</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Survey</keyword>
	<keyword>Decision tool</keyword>
	<keyword>Contralateral Prophylactic Mastectomy</keyword>
</DOC>